KP

Kumari Priyanka

Active Director Director DIN 10906847
DIN 10906847 First appointment Jan 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Kumari Priyanka

Data last updated:

Kumari Priyanka is a Director at Syngonium Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 10906847
Primary Designation Director
Industry Pharma
First Appointment 14 Jan 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director14 Jan 20252025Active

Board colleagues of Kumari Priyanka

NameDINCompanyDesignation
Bimlesh Kumar08196891Syngonium Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Syngonium Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Kumari Priyanka

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kumari Priyanka

Kumari Priyanka currently holds 1 directorship: Syngonium Pharmaceuticals Private Limited (Director, since 14 Jan 2025).

Kumari Priyanka was first appointed on 14 Jan 2025 as Director at Syngonium Pharmaceuticals Private Limited.

The current boards of Kumari Priyanka's companies include Bimlesh Kumar (Syngonium Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available